Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Mackenzie

Showing results (261-270 of 368) with videos related to

Pageof 37
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|August 27, 2005
Human UDP-glucuronosyltransferase 1A5: identification, expression, and activityMoshe Finel, Xin Li, Dione Gardner-Stephen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 9, 2006
Inhibition of UDP-glucuronosyltransferase 2b7-catalyzed morphine glucuronidation by ketoconazole: dual mechanisms involving a novel noncompetitive modeShuso Takeda, Yurie Kitajima, Yuji Ishii, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 1, 1997
Comparison of stably expressed rat UGT1.1 and UGT2B1 in the glucuronidation of opioid compoundsC D King, G R Rios, M D Green, et al.
Biochemical Pharmacology|September 18, 2012
Effects of amino acid substitutions at positions 33 and 37 on UDP-glucuronosyltransferase 1A9 (UGT1A9) activity and substrate selectivityPorntipa Korprasertthaworn, Andrew Rowland, Benjamin C Lewis, et al.
Ecology|July 3, 2007
Occupancy estimation and modeling with multiple states and state uncertaintyJames D Nichols, A James E Hines, Darryl I Mackenzie, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 24, 2007
Binding of inhibitory fatty acids is responsible for the enhancement of UDP-glucuronosyltransferase 2B7 activity by albumin: implications for in vitro-in vivo extrapolationAndrew Rowland, Paraskevi Gaganis, David J Elliot, et al.
Cancers|September 10, 2021
The Expression Profiles and Deregulation of UDP-Glycosyltransferase (<i>UGT</i>) Genes in Human Cancers and Their Association with Clinical OutcomesDong Gui Hu, Shashikanth Marri, Peter I Mackenzie, et al.
Molecular Pharmacology|July 24, 2008
Kinetic modeling of the interactions between 4-methylumbelliferone, 1-naphthol, and zidovudine glucuronidation by udp-glucuronosyltransferase 2B7 (UGT2B7) provides evidence for multiple substrate binding and effector sitesVerawan Uchaipichat, Aleksandra Galetin, J Brian Houston, et al.
Gut|May 1, 1976
Proceedings: The significance and management of arterial hypoxia in acute pancreatitisC W Imrie, J C Ferguson, D Murphy, et al.
Physical Chemistry Chemical Physics : PCCP|November 20, 2012
Increasing organic solar cell efficiency with polymer interlayersFelix Deschler, Daniel Riedel, Bernhard Ecker, et al.
Pageof 37

Showing results (261-270 of 368) with videos related to

Sort By:
Pageof 37
The Journal of Pharmacology and Experimental Therapeutics|August 27, 2005
Human UDP-glucuronosyltransferase 1A5: identification, expression, and activityMoshe Finel, Xin Li, Dione Gardner-Stephen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 9, 2006
Inhibition of UDP-glucuronosyltransferase 2b7-catalyzed morphine glucuronidation by ketoconazole: dual mechanisms involving a novel noncompetitive modeShuso Takeda, Yurie Kitajima, Yuji Ishii, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 1, 1997
Comparison of stably expressed rat UGT1.1 and UGT2B1 in the glucuronidation of opioid compoundsC D King, G R Rios, M D Green, et al.
Biochemical Pharmacology|September 18, 2012
Effects of amino acid substitutions at positions 33 and 37 on UDP-glucuronosyltransferase 1A9 (UGT1A9) activity and substrate selectivityPorntipa Korprasertthaworn, Andrew Rowland, Benjamin C Lewis, et al.
Ecology|July 3, 2007
Occupancy estimation and modeling with multiple states and state uncertaintyJames D Nichols, A James E Hines, Darryl I Mackenzie, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 24, 2007
Binding of inhibitory fatty acids is responsible for the enhancement of UDP-glucuronosyltransferase 2B7 activity by albumin: implications for in vitro-in vivo extrapolationAndrew Rowland, Paraskevi Gaganis, David J Elliot, et al.
Cancers|September 10, 2021
The Expression Profiles and Deregulation of UDP-Glycosyltransferase (<i>UGT</i>) Genes in Human Cancers and Their Association with Clinical OutcomesDong Gui Hu, Shashikanth Marri, Peter I Mackenzie, et al.
Molecular Pharmacology|July 24, 2008
Kinetic modeling of the interactions between 4-methylumbelliferone, 1-naphthol, and zidovudine glucuronidation by udp-glucuronosyltransferase 2B7 (UGT2B7) provides evidence for multiple substrate binding and effector sitesVerawan Uchaipichat, Aleksandra Galetin, J Brian Houston, et al.
Gut|May 1, 1976
Proceedings: The significance and management of arterial hypoxia in acute pancreatitisC W Imrie, J C Ferguson, D Murphy, et al.
Physical Chemistry Chemical Physics : PCCP|November 20, 2012
Increasing organic solar cell efficiency with polymer interlayersFelix Deschler, Daniel Riedel, Bernhard Ecker, et al.
Pageof 37